Valeant Pharmaceuticals

Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareholders and Pershing, Valeant -- Update
Morningstar
Wed, 01/17/18 - 11:27 am
Allergan
shareholders
Valeant Pharmaceuticals
M&A
Valeant strikes deal to reduce its portion of Allergan settlement to $96.25M
Canadian Business
Mon, 01/1/18 - 03:06 pm
Valeant Pharmaceuticals
Allergan
M&A
Valeant’s unstoppable rise: +50% since January 2017
GoinPharma
Wed, 12/13/17 - 06:41 pm
Valeant Pharmaceuticals
Insider trading case against Ackman, Valeant approaches trial: report
Fierce Pharma
Tue, 12/12/17 - 10:41 pm
insider trading
Valeant Pharmaceuticals
Bill Ackman
Specialty pharmacy scrutiny hits again with state's focus on Horizon meds
Fierce Pharma
Sat, 12/9/17 - 02:26 pm
specialty pharmacies
Horizon Pharma
Express Scripts
Valeant Pharmaceuticals
[video]Is Valeant Turning Things Around?
Motley Fool
Wed, 11/15/17 - 08:30 am
Valeant Pharmaceuticals
Last week in pharma.bio.device.lab November 5-11 2017
CP Wire
Sun, 11/12/17 - 02:24 pm
layoffs
Eli Lilly
Genentech
Amgen
Valeant Pharmaceuticals
Addyi
FDA
Scott Gottlieb
physician payments
3 Biotech Stocks That Soared This Week
Motley Fool
Sun, 11/12/17 - 10:32 am
biotech
Nektar
earnings
SAGE Therapeutics
brexanolone
postpartum depression
Valeant Pharmaceuticals
Valeant Pharmaceuticals Posts a Huge Third-Quarter Profit -- but There's a Catch
Motley Fool
Tue, 11/7/17 - 09:26 pm
Valeant Pharmaceuticals
earnings
Valeant hands off its controversial, $1B female libido drug to Sprout backers in sweetheart deal
Endpoints
Mon, 11/6/17 - 09:07 am
Valeant Pharmaceuticals
Addyi
female sexual dysfunction
Sprout Pharmaceuticals
Earnings Preview: What To Expect From Valeant Pharmaceuticals On Tuesday
Forbes
Sat, 11/4/17 - 05:31 pm
earnings
Valeant Pharmaceuticals
Valeant finally wins long-delayed FDA OK for its glaucoma drug, which is more good news for Aerie
Endpoints
Thu, 11/2/17 - 10:19 pm
Valeant Pharmaceuticals
FDA
glaucoma
Aerial BioPharma
Vyzulta
Rhopressa
How Low Does Valeant Pharmaceuticals' Debt Really Need to Go?
Motley Fool
Tue, 09/26/17 - 10:53 am
Valeant Pharmaceuticals
debt
Here's the Simple Issue I Still Have With Valeant Pharmaceuticals
Motley Fool
Thu, 08/24/17 - 09:50 am
Valeant Pharmaceuticals
Aerie boosted as Valeant’s troubled Tampa facility looks like it’s coming out of rehab
Endpoints
Thu, 08/17/17 - 10:05 am
Aerie Pharma
Valeant Pharmaceuticals
drug manufacturing
Rhopressa
Positive signs from Valeant, market rewards it
GoInPharma
Sat, 08/12/17 - 11:57 am
Valeant Pharmaceuticals
5 Reasons Valeant's Situation Could Get Worse
Motley Fool
Thu, 08/10/17 - 12:02 pm
Valeant Pharmaceuticals
LOEs
dermatology
debt
Valeant gets 2nd CRL for eye drug, stung again by manufacturing failings
Fierce Pharma
Wed, 08/9/17 - 09:33 am
Valeant Pharmaceuticals
CRL
latanoprostene bunod
open angle glaucoma
Valeant turnaround still a fantasy
BioPharma Dive
Tue, 08/8/17 - 11:27 am
Valeant Pharmaceuticals
FDA's generic competition push hits Valeant's Isuprel, a price-hike poster child
Fierce Pharma
Tue, 08/8/17 - 10:03 am
FDA
generics
Valeant Pharmaceuticals
Isuprel
drug pricing
nexus

Pages